| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Apr 12, 2021 | Option/RSU Exercise | $1.86 | 1,200 | 2,232 | 2,005 | Apr 13, 2021, 05:20 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Apr 12, 2021 | Sale | $27.20 | 1,200 | 32,640 | 805 | Apr 13, 2021, 05:20 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Mar 10, 2021 | Option/RSU Exercise | $1.86 | 2,000 | 3,720 | 2,805 | Mar 11, 2021, 05:35 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Mar 10, 2021 | Sale | $41.27 | 2,000 | 82,539 | 1,905 | Mar 11, 2021, 05:35 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Feb 18, 2021 | Option/RSU Exercise | $1.86 | 2,000 | 3,720 | 2,000 | Feb 22, 2021, 04:08 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Feb 18, 2021 | Sale | $35.88 | 2,000 | 71,750 | 1,600 | Feb 22, 2021, 04:08 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More